NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis. 2023

Paolo Preziosa, and Elisabetta Pagani, and Alessandro Meani, and Olga Marchesi, and Lorenzo Conti, and Andrea Falini, and Maria A Rocca, and Massimo Filippi
Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy.

BACKGROUND Pathologically specific MRI measures may elucidate in-vivo the heterogeneous processes contributing to cognitive impairment in multiple sclerosis (MS). OBJECTIVE Using diffusion tensor and neurite orientation dispersion and density imaging (NODDI), we explored the contribution of focal lesions and normal-appearing (NA) tissue microstructural abnormalities to cognitive impairment in MS. METHODS One hundred and fifty-two MS patients underwent 3 T brain MRI and a neuropsychological evaluation. Forty-eight healthy controls (HC) were also scanned. Fractional anisotropy (FA), mean diffusivity (MD), intracellular volume fraction (ICV_f) and orientation dispersion index (ODI) were assessed in cortical and white matter (WM) lesions, thalamus, NA cortex and NAWM. Predictors of cognitive impairment were identified using random forest. RESULTS Fifty-two MS patients were cognitively impaired. Compared to cognitively preserved, impaired MS patients had higher WM lesion volume (LV), lower normalized brain volume (NBV), cortical volume (NCV), thalamic volume (NTV), and WM volume (p ≤ 0.021). They also showed lower NAWM FA, higher NAWM, NA cortex and thalamic MD, lower NAWM ICV_f, lower WM lesion ODI, and higher NAWM ODI (false discovery rate-p ≤ 0.026). Cortical lesion number and microstructural abnormalities were not significantly different. The best MRI predictors of cognitive impairment (relative importance) (out-of-bag area under the curve = 0.727) were NAWM FA (100%), NTV (96.0%), NBV (84.7%), thalamic MD (43.4%), NCV (40.6%), NA cortex MD (26.0%), WM LV (23.2%) and WM lesion ODI (17.9%). CONCLUSIONS Our multiparametric MRI study including NODDI measures suggested that neuro-axonal damage and loss of microarchitecture integrity in focal WM lesions, NAWM, and GM contribute to cognitive impairment in MS.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001284 Atrophy Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. Atrophies
D016501 Neurites In tissue culture, hairlike projections of neurons stimulated by growth factors and other molecules. These projections may go on to form a branched tree of dendrites or a single axon or they may be reabsorbed at a later stage of development. "Neurite" may refer to any filamentous or pointed outgrowth of an embryonal or tissue-culture neural cell. Neurite
D060825 Cognitive Dysfunction Diminished or impaired mental and/or intellectual function. Cognitive Disorder,Mild Cognitive Impairment,Cognitive Decline,Cognitive Impairments,Mental Deterioration,Cognitive Declines,Cognitive Disorders,Cognitive Dysfunctions,Cognitive Impairment,Cognitive Impairment, Mild,Cognitive Impairments, Mild,Decline, Cognitive,Declines, Cognitive,Deterioration, Mental,Deteriorations, Mental,Disorder, Cognitive,Disorders, Cognitive,Dysfunction, Cognitive,Dysfunctions, Cognitive,Impairment, Cognitive,Impairment, Mild Cognitive,Impairments, Cognitive,Impairments, Mild Cognitive,Mental Deteriorations,Mild Cognitive Impairments
D066127 White Matter The region of CENTRAL NERVOUS SYSTEM that appears lighter in color than the other type, GRAY MATTER. It mainly consists of MYELINATED NERVE FIBERS and contains few neuronal cell bodies or DENDRITES. Cerebellar White Matter,Cerebellar White Matters,Matter, Cerebellar White,Matter, White,Matters, Cerebellar White,Matters, White,White Matter, Cerebellar,White Matters,White Matters, Cerebellar
D066128 Gray Matter Region of CENTRAL NERVOUS SYSTEM that appears darker in color than the other type, WHITE MATTER. It is composed of neuronal CELL BODIES; NEUROPIL; GLIAL CELLS and CAPILLARIES but few MYELINATED NERVE FIBERS. Cerebellar Gray Matter,Cerebellar Grey Matter,Grey Matter,Cerebellar Gray Matters,Cerebellar Grey Matters,Gray Matter, Cerebellar,Gray Matters,Gray Matters, Cerebellar,Grey Matter, Cerebellar,Grey Matters,Grey Matters, Cerebellar,Matter, Cerebellar Gray,Matter, Cerebellar Grey,Matter, Gray,Matter, Grey,Matters, Cerebellar Gray,Matters, Cerebellar Grey,Matters, Gray,Matters, Grey

Related Publications

Paolo Preziosa, and Elisabetta Pagani, and Alessandro Meani, and Olga Marchesi, and Lorenzo Conti, and Andrea Falini, and Maria A Rocca, and Massimo Filippi
December 2016, International journal of molecular sciences,
Paolo Preziosa, and Elisabetta Pagani, and Alessandro Meani, and Olga Marchesi, and Lorenzo Conti, and Andrea Falini, and Maria A Rocca, and Massimo Filippi
March 2006, Neurology,
Paolo Preziosa, and Elisabetta Pagani, and Alessandro Meani, and Olga Marchesi, and Lorenzo Conti, and Andrea Falini, and Maria A Rocca, and Massimo Filippi
May 2010, Radiology,
Paolo Preziosa, and Elisabetta Pagani, and Alessandro Meani, and Olga Marchesi, and Lorenzo Conti, and Andrea Falini, and Maria A Rocca, and Massimo Filippi
March 2021, Diagnostics (Basel, Switzerland),
Paolo Preziosa, and Elisabetta Pagani, and Alessandro Meani, and Olga Marchesi, and Lorenzo Conti, and Andrea Falini, and Maria A Rocca, and Massimo Filippi
January 2013, NeuroImage. Clinical,
Paolo Preziosa, and Elisabetta Pagani, and Alessandro Meani, and Olga Marchesi, and Lorenzo Conti, and Andrea Falini, and Maria A Rocca, and Massimo Filippi
April 2015, AJNR. American journal of neuroradiology,
Paolo Preziosa, and Elisabetta Pagani, and Alessandro Meani, and Olga Marchesi, and Lorenzo Conti, and Andrea Falini, and Maria A Rocca, and Massimo Filippi
January 2020, Scientific reports,
Paolo Preziosa, and Elisabetta Pagani, and Alessandro Meani, and Olga Marchesi, and Lorenzo Conti, and Andrea Falini, and Maria A Rocca, and Massimo Filippi
January 2013, Diabetes care,
Paolo Preziosa, and Elisabetta Pagani, and Alessandro Meani, and Olga Marchesi, and Lorenzo Conti, and Andrea Falini, and Maria A Rocca, and Massimo Filippi
January 2022, Nature reviews. Neurology,
Paolo Preziosa, and Elisabetta Pagani, and Alessandro Meani, and Olga Marchesi, and Lorenzo Conti, and Andrea Falini, and Maria A Rocca, and Massimo Filippi
July 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging,
Copied contents to your clipboard!